Regression of hepatic tumors during transdermal estradiol replacement therapy

Keyphrases

• Replacement Therapy 100%
• Hepatic Tumor 100%
• Transdermal Estradiol 100%
• Estradiol Replacement 100%
• Oral Contraceptives 50%
• Ultrasonographic Examination 50%
• Hepatic Lesion 50%
• Computational Imaging 25%
• Oral Contraceptive Use 25%
• Young Age 25%
• Imaging Techniques 25%
• Liver Enzymes 25%
• Liver 25%
• Liver Function Tests 25%
• Salpingo-oophorectomy 25%
• Total Abdominal Hysterectomy 25%
• Ultrasound Imaging 25%
• Liver Function 25%
• Sonography 25%
• Hormone Replacement Therapy 25%
• Complete Regression 25%
• Pelvic Pain 25%
• Adnexa 25%
• Therapy Discontinuation 25%
• Liver Scan 25%
• Systemic Absorption 25%
• Pelvic Endometriosis 25%
• Liver Ultrasound 25%
• Hepatic First-pass Effects 25%
• Liver CT 25%
• Scanning Imaging 25%

Medicine and Dentistry

• Substitution Therapy 100%
• Liver Tumor 100%
• Transdermal 100%
• Diethylstilbestrol 100%
• Oral Contraceptive 50%
• Liver Injury 50%
• Oral Contraceptive Use 25%
• Liver Enzyme 25%
• Liver Function Test 25%
• Pelvis 25%
• Endometriosis 25%
• Abdominal Hysterectomy 25%
• Salpingooophorectomy 25%
• Ultrasonography 25%
• Echography 25%
• Liver Function 25%
• Imaging Technique 25%
• Hormone Substitution 25%
• Pelvic Pain 25%
• Adnexa 25%
• Liver Scintiscanning 25%